000 | 00652 a2200181 4500 | ||
---|---|---|---|
005 | 20250515214004.0 | ||
264 | 0 | _c20100318 | |
008 | 201003s 0 0 eng d | ||
022 | _a0097-0506 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDORN, H W | |
245 | 0 | 0 |
_aProtein hydrolyzates. _h[electronic resource] |
260 |
_bBulletin. American Pharmaceutical Association. Committee on National Formulary _c |
||
300 |
_a57-65 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aProtein Hydrolysates |
773 | 0 |
_tBulletin. American Pharmaceutical Association. Committee on National Formulary _gvol. 15 _gno. 3-4 _gp. 57-65 |
|
999 |
_c19658423 _d19658423 |